Abstract：Objective To observe the motions of the rectum and bladder by image-guided radiotherapy (IGRT) and to analyze their impact on treatment. Methods Eighteen patients with prostate cancer undergoing intensity-modulated radiotherapy (IMRT) were enrolled in the study and 247 cone-beam computed tomography (CBCT) images were obtained from this study. The clinical target volume, bladder, and rectum were contoured on all simulated CT and CBCT to examine their volume and position changes. The dose distributions were recalculated based on the data of the x-, y-, and z-axis setup errors. The doses to planning target volume (PTV) and organs at risk were calculated in the replanning, and their impact on treatment was analyzed. Comparison of the planning and replanning Results was made by paired t-test. The effects of displacements and volumes of the bladder and rectum on target doses were analyzed by Pearson correlation method. Results Great changes in the volumes of the bladder and rectum were observed during the treatment. For the planning and replanning results, PTVD95% was 7777.37 cGy vs. 7628.56 cGy (P=0.027), PTVDmin was 87.91 cGy vs. 83.35 cGy (P=0.000), and RVP was 5.89% vs. 8.31%(P=0.000). There were correlations between PTVD95% and the motions of the bladder and rectum, with correlation coefficients of 0.296 and 0.177, respectively. The correlation coefficient between rectal volume and PTVD95% was 0.115, indicating a certain correlation. There is a certain correlation between and PTVDmin and bladder volume, with a correlation coefficient of-0.128. Conclusions The recovery of the state during localization for the bladder and rectum, especially the latter, has great significance to ensure the target dose and reduce exposure of the rectum in the IMRT for prostate cancer.
Li Ming,Lin Hailei,Xiu Xia et al. Effects of bladder and rectum management on dose distributions of target and organs at risk in intensity-modulated radiotherapy for prostate cancer[J]. Chinese Journal of Radiation Oncology, 2015, 24(6): 644-648.
[1] van Herk M.Errors and margins in radiotheropy[J].Semin Radiat,2004,14(1):52-64.DOI:10.1053/j.semradonc.2003.10.003. [2] Linda JB,Jennifer C,Thomas E,et al. The impact of rectal and bladder variability on target coverage duringpost-prostatectomy intensity modulated radiotherapy[J].Radiother Oncol,2014,110(2):245-250.DOI:10.1016/j.radonc.2013.10.042. [3] Ghilezan MJ,Jaffray DA,Siewerdsen JH,et al. Prostate gland motionassessed with cine—magnetic resonance imaging (cine-MRI)[J].Int J Radiat Oncol Biol Phys,2005,62(2):406-417.DOI:10.1016/j.ijrobp.2003.10.017. [4] Padhani AR,Khoo VS,Suckling J,et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI[J].Int J Radiat Oncol Biol Phys,1999,44(3):525-533.DOI:10.1016/S0360-3016(99)00040-1. [5] de Crevoisier R,Tucker SL,Dong L,et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy[J].Int J Radiat Oncol Biol Phys,2005,62(4):965-973.DOI:10.1016/j.ijrobp.2004.11.032. [6] Ramachandran Prabhakan P,Richard O,Daryl J,et al. A study on planning organ at risk volume for the rectum using cone beam computed tomography in the treatment of prostate cancer[J]. Med Dosi,2014,39(1):38-43.DOI:10.1016/j.meddos.2013.09.003. [7] Hüttenrauch P,Witt M,Wolff D,et al. Target volume coverage and dose to organs at risk in prostate cancer patients[J].Strahlenther Onkol,2014,190(3):310-316.DOI:10.1007/s00066-013-0483-2. [8] Jennifer L. P, Steven J. B,Michael G. H,et al. Image-guided intensity-modulated radiotherapy for prostate cancer:Dose constraints for the anterior rectal wall to minimize rectal toxicity. Med Dosim,2014,39(1):12-17.doi:10.1016/j.meddos.2013.08.007. [9] An Q,Ying S,Jian L,Evaluation of Online/Offline ImageGuidance/Adaptation Approaches for ProstateCancer Radiation Therapy[J]. Int J Radiat Oncol Biol Phys,2015,91(5):1026-1033.DOI:10.1016/j.ijrobp.2014.12.043. [10] Arnaud A,Maingon P, Gauthier M,et al. Image-guided IMRT for localized prostate cancer with dailyrepositioning:Inferring the difference between planned dose anddelivered dose distribution[J]. Phys Med,2014,30(6):669-675.DOI:10.1016/j.ejmp.2014.04.006. [11] Maund IF,Benson RJ,Fairfoul J,et al. Image-guided radiotherapy of the prostate using dailyCBCT:the feasibility and likely benefit of implementinga margin reduction[J]. Br J Radiol,2014,87(1044):459.DOI:10.1259/bjr.20140459. [12] Isabellle G,Jean-Francois C,Dominic B,et al. Dosimetric impactandtheoretical clinicalbenifitsoffiducialmarkers for dose escalated prostate cancer radiation treatment[J].Int J Radiat Oncol Biol Phys,2009,74(4):1128-1133.DOI:10.1016/j.ijrobp.2008.09.043.
2015, Vol. 24 
